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The redox environment triggers 
conformational changes and 
aggregation of hIAPP in Type II 
Diabetes
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Type II diabetes (T2D) is characterized by diminished insulin production and resistance of cells to 
insulin. Among others, endoplasmic reticulum (ER) stress is a principal factor contributing to T2D and 
induces a shift towards a more reducing cellular environment. At the same time, peripheral insulin 
resistance triggers the over-production of regulatory hormones such as insulin and human islet amyloid 
polypeptide (hIAPP). We show that the differential aggregation of reduced and oxidized hIAPP assists 
to maintain the redox equilibrium by restoring redox equivalents. Aggregation thus induces redox 
balancing which can assist initially to counteract ER stress. Failure of the protein degradation machinery 
might finally result in β-cell disruption and cell death. We further present a structural characterization of 
hIAPP in solution, demonstrating that the N-terminus of the oxidized peptide has a high propensity to 
form an α-helical structure which is lacking in the reduced state of hIAPP. In healthy cells, this residual 
structure prevents the conversion into amyloidogenic aggregates.
Type II diabetes (T2D) is the most common form of diabetes. The disease is caused by a combination of genetic 
and environmental factors, and results in insulin resistance and β -cell failure1. T2D is also linked to the tissue 
inflammation response2. The exact patho-mechanism of the disease is, however, not understood so far. In addi-
tion to insulin resistance, lipotoxicity, endoplasmic reticulum (ER) and oxidative stress, as well as amyloid dep-
osition have been described as secondary effects of the disease2. The amyloid plaques formed within the β -cells 
of the pancreatic islets of Langerhans3 are composed of the 37 amino acid polypeptide human Islet Amyloid 
Polypeptide (hIAPP). In recent studies it has been shown that soluble oligomers of this hormone are responsible 
for cell toxicity4,5. Yet until now, it is not understood how hIAPP changes from a functional into a pathophysio-
logical form. In vivo, hIAPP is soluble at concentrations of 1–4 mM6–8, while in vitro hIAPP aggregates at 1000 
times lower concentrations. Protein aggregation is influenced by concentration and pH9. In T2D, the redox state 
of the ER is shifted towards more reducing conditions, resulting in protein secretion and folding deficiencies10–12. 
So far, it is unclear how this change of the redox environment affects hIAPP aggregation. We show here that the 
redox conditions play an important role in the aggregation of hIAPP. Furthermore, we present the first detailed 
structural analysis of monomeric hIAPP in aqueous buffer. We find that the disulfide bridge in hIAPPox stabilizes 
an α -helical structure at the N-terminus of the peptide, and thus protects the peptide from aggregation.
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Results
Assembly Kinetics of hIAPP. To better understand the influence of the redox environment on the aggre-
gation kinetics of hIAPP, we first performed Thioflavin T (ThT) assays. In a cell, the ratio of reduced glutathione 
(GSH) to oxidized glutathione (GSSG) is often employed as a measure of cellular oxidative stress. In order to 
induce a particular oxidative state of hIAPP, we added the redox couple GSH/GSSG to the peptide solution 
(Fig. 1A,B). A sigmoidal fit of the ThT results yields the time at which the half-maximum fluorescence intensity 
has been obtained (T50). We found that the aggregation kinetics of hIAPP are affected by the oxidative environ-
ment. hIAPPred aggregates faster in comparison to hIAPPox. However, mixtures of hIAPPred and hIAPPox yield 
the same rate of aggregation as hIAPPred. Within the experimental error, we found the same T50 values for redox 
pairs that yield (100:0)%, (80:20)% or (50:50)% reduced and oxidized hIAPP. This suggests that the aggregation 
of hIAPP is controlled by the reduced form. The ThT results are supported by NMR experiments which show that 
hIAPPred has a 3-times faster aggregation kinetics in comparison to hIAPPox (Fig. 1C). To validate the biological 
significance of the differential aggregation behaviour of hIAPPox and hIAPPred, we determined the redox potential 
for the formation of the disulfide bond in hIAPP using NMR spectroscopy. 1H,15N HSQC spectra were recorded 
after incubating the protein with varying ratios of reduced and oxidized glutathione. A plot of the average peak 
intensities as a function of the [GSH]2/[GSSG] ratio is shown in Fig. 1D. As a secondary abscissa, the calculated 
redox potential is represented. Using the Nernst equation with the respective correction for temperature and 
pH13, we calculated a redox potential of (− 129 ± 4) mV for hIAPP. The ER has an electrochemical potential that 
varies between − 231 to − 160 mV, and is dependent on the employed method14. Under these conditions, less than 
30% of the peptide exists in the oxidized state. This theoretical redox state assumes quasi-equilibration with the 
redox couple GSH/GSSG.
To analyze the hIAPP oxidation state in vivo, we used a transgenic mouse model (FVB/N-Tg(Ins2-IAPP)
RHFSoel/J) in which the human IAPP sequence has been incorporated into the mouse genome on chromosome 
15 (https://www.jax.org/strain/008232). We found that the morphology of the islets is dramatically changed for 
transgenic mice that harbor two human gene copies (TG/TG) (Fig. 1F, left) compared to healthy controls. We 
employed a fibril specific antibody to study whether amyloid fibrils participate in this process. We found amyloid 
fibrils in insulin producing β -cells in TG/TG animals (Fig. 1F). These were not present in healthy animals. These 
results suggest that amyloid fibrils in TG/TG mice potentially induce impaired islet morphology. To quantify 
the amount of reduced or oxidized hIAPP in vivo, we added N-ethylmaleimide (NEM) to TG/TG and + /+ 
mouse islets to yield an alkylation of free sulfhydryl groups. NEM has the ability to cross cellular membranes and 
thus does not require cell lysis. Modified hIAPPred-NEM yielded an increased molecular weight which could be 
detected by SDS-PAGE. Soluble oligomeric hIAPP could be identified using the hIAPP specific antibody A13315. 
In TG/TG islets, both reduced and oxidized hIAPP were found (Fig. 1E, right). As expected, no aggregates were 
found in the islets of the+ /+ control mice (Fig. 1E, right). As a reference, an aggregated sample of recombinant, 
oxidized hIAPP was investigated as well (Fig. 1E, left). We observed that samples that were taken at a later time 
point yielded a more disperse distribution of oligomeric states. An incubation time of 72 h for an oxidized hIAPP 
sample produced a gel band at approximately 60 kDa, which corresponds in molecular weight to the band of the 
hIAPP sample extracted from the diabetes mouse model islets (Fig. 1E, right, last sample).
In order to probe if the differential aggregation behavior results in a continuous conversion of hIAPPox into 
hIAPPred at defined redox conditions, electron microscopic (EM) images of hIAPP aggregates that are obtained 
in buffers with different amounts of GSH and GSSG were recorded (Fig. 2A–C). Under conditions, in which the 
redox equilibrium is shifted to produce a defined amount of hIAPPox (50:50 = hIAPPred:hIAPPox) (Fig. 2C), the 
fibril morphology resembles the morphology obtained for the pure hIAPPred (Fig. 2B). By contrast, pure hIAPPox 
(Fig. 2A) showed a different fibril morphology. To confirm this observation, we carried out solution-state HSQC 
NMR experiments of hIAPP aggregates that were dissolved in DMSO prior to the experiment. These experiments 
allow to probe the hIAPP redox state of the hIAPP aggregates. Again, we found that the hIAPP spectra of the sam-
ples in which the redox properties in the buffer has been adjusted to yield 100% hIAPPred or a 1:1 ratio of hIAP-
Pox and hIAPPred are rather similar, whereas the sample containing pure hIAPPox looked significantly different 
(Fig. 2E). This indicates that aggregation in fact shifts the equilibrium to the reduced state of the peptide. Based 
on these results, we suggest a model for hIAPP aggregation in the cell that is dependent on its particular redox 
environment (Fig. 2F). External factors such as oxidative stress or ER stress, hyperglycemia, lipotoxity, or genetic 
factors have an impact on the ER redox state. A small shift of the redox conditions can result in generation of a 
small amount of hIAPPred. hIAPPred preferentially aggregates and is depleted from the pool of hIAPP molecules in 
solution. As the redox state in the cell is buffered, more hIAPPox is transformed to its reduced form which again 
has a higher propensity to form fibrils. Eventually, all available hIAPP is converted into its reduced state which is 
finally deposited in insoluble aggregates.
Structural analysis of hIAPP. To study the mechanism of hIAPP aggregation, the conformation of the 
peptide was determined under physiological conditions. Recombinant C-terminal amidated hIAPP(1-37) was 
produced using the protocol published recently17. hIAPP has a strong tendency to aggregate in aqueous buffer. 
However, low pH (pH 5.3), temperature (4 °C) and concentration (100 μ M) reduced the rate of fibril formation. 
Under these conditions, hIAPP(1-37) yielded a CD spectrum which contained contributions from α -helix and 
random coil secondary structure (Fig. 3A). Comparison of the oxidized and the reduced form of the peptide 
suggests that a loss of the disulfide bond induces a loss of the α -helical structure. To support this observation, 
we recorded solution-state NMR experiments. 1H,15N HSQC spectra of reduced and oxidized hIAPP yielded 
significant chemical shift differences, in particular for Cys-2 and Cys-7 as well as for residues in the vicinity of 
the disulfide bond (Fig. 2D). Chemical shift assignments have been obtained from 3D HNCACB experiments18. 
The analysis of 13 Cα/β secondary chemical shifts reveals a strong helical propensity for the N-terminal half of the 
oxidized hIAPP (residues 5-17), and a random coil conformation for the C-terminal half of the peptide (Fig. 3E). 
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Figure 1. (A) Thioflavin T (ThT) assay using a solution of 35 μ M of hIAPP, pH 5.3 and 30 °C. Experiments were 
performed by adding defined amounts of GSH and GSSG to yield varying percentages of reduced and oxidized 
hIAPP in solution. In all three curves, ThT fluorescence intensities are normalized to 1. ThT fluoresence curves 
with absolute intensities are represented in Fig. S2. (B) T50 values for hIAPP aggregation for different redox 
conditions. T50 corresponds to the time that is required to reach half-maximum ThT fluoresence intensity. 
(C) Aggregation kinetics of hIAPPox and hIAPPred measured by solution-state NMR. hIAPPred aggregates 
significantly faster in comparison to hIAPPox. The intensities of the NMR resonances directly indicate the 
amount of soluble hIAPPox and hIAPPred.  Both peptides were solubilized at a concentation of 100 μM in 
aqueous buffer (30 mM acetic acid, pH 5.3, 4 °C) (D) Determination of the electrochemical potential of hIAPP. 
The relative amount of hIAPPox is represented as a function of the concentrations of GSH and GSSG. For 
the analysis, the peak intensity of Cys-7 has been employed. The redox potential of hIAPP was determined 
as − 129 ± 4 mV using the protocol described by Zimmermann et al.16. (E) Western blot of in vitro and in vivo 
formed hIAPP aggregates. Left: Purified, recombinant hIAPP after an incubation time of 3 h and 12 h in solution 
yields SDS-stable hIAPP oligomers. The oligomeric state is increased at prolonged incubation times. Right: 
Sample extracted from pancreatic islets from diabetic TG/TG and non-diabetic+ /+ mice. The oxidation state 
of cysteines was blocked with NEM in an alkylation reaction which produced a modified hIAPPred exhibiting 
a larger molecular weight. The high molecular weight bands were observed only in the TG/TG mouse sample. 
hIAPP was identified using the antibody A13315. This antibody is monoclonal against hIAPP(20–29) and 
is specific for the human sequence. No interference with alkylated hIAPP can thus be expected. (F) Light 
microscopy (left) and histological immunofluorescence images (right) of islets from + /+ control mice and  
TG/TG mice. Insulin is indicated in green, amyloid fibrils in red, nuclei in blue. + /+ control mice do not 
display any morphological changes. Amyloid aggregates are observed using an antibody against amyloid 
fibrils in islets of TG/TG mice. The white scale bar denotes 100 μ m. Figure S1 shows that the antibody 91D7E8 
speciflcally detects IAPP fibrils.
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The same analysis for the reduced form of hIAPP showed a smaller helical propensity for the N-terminal half, 
suggesting that the N-terminal disulfide bond stabilizes the helical conformation. The observation that hIAPPox 
has a diminished tendency to aggregate stimulated a more detailed structural characterization of the peptide. For 
the structural analysis, 3D 13C/15N edited NOESY-HSQC data were collected for hIAPPox. The faster aggregation 
kinetics of hIAPPred prohibited a detailed structural characterization. The ensemble of the 20 lowest energy struc-
tures obtained after water refinement is shown in Fig. 3B,C. A summary of the structural and restraint statistics 
is given in Table 1. We note that no hydrogen bonding restraints were included in the structure calculations 
to enforce an α -helical conformation. The present solution structure of native hIAPP (oxidized and amidated) 
shares similarities, but also has differences when compared to other structures of amylin reported under various 
conditions19. A common theme in all structures is the N-terminal loop closed by the disulfide bond followed by a 
right-handed α -helix. In our study, the oxidation state of the peptide was confirmed by the 13Cβ secondary chemi-
cal shifts of the two cysteines (Cys-2 and Cys-7). In our analysis, the α -helix spans residues 8–17. In particular, the 
helical structure was confirmed by the characteristic α N(i,i+ 3), α N(i,i+ 4) and α β (i,i+ 3) NOEs (Fig. 3D,G,H). 
We found that the histidine at position 18 is incompatible with an α -helical conformation. His-18 thus introduces 
a kink in line with earlier findings (Fig. 3C)20. For the C-terminal part, the NOE pattern of the 15N-edited 3D 
NOESY experiment was dominated by strong correlations between the respective amides and the (i− 1) Hα atoms 
which is typical for IDPs (Intrinsically Disordered Proteins). In addition, no long-range NOEs were detected for 
the C-terminal amide suggesting that cross-talk to distant residues is not occuring. The structural model is sup-
ported by {1H},15N heteronuclear NOE data that showed a certain rigidity for the N-terminal half and increased 
flexibility towards the C-terminus of hIAPP (Fig. 3F).
Figure 2. (A–C) EM images of fibrils formed in the presence of different ratios of the GSH-GSSG redox 
couple. In (A) hIAPP was incubated using 2 mM GSSG to produce a completely oxidized hIAPP. (B) hIAPP 
was incubated using 35 mM GSH yielding 100% hIAPPred, whereas in (C) hIAPP was incubated in a buffer 
containing 0.2 mM GSSG and 4.98 mM GSH yielding 50% hIAPPred and 50% hIAPPox. The scale bar denotes 
200 nm. (D) 1H,15N-HSQC spectra of the reduced (red) and oxidized (black) hIAPP in aqueous buffer (30 mM 
acetic acid, pH 5.3). Amino acids are labelled according to their type and sequence number. Major chemical 
shift changes upon disulfide bond formation are indicated by black dashed lines. The NMR chemical shifts are 
deposited in the BMRB (BMRB ID: 34069). (E) 1H,15N HSQC spectra to probe the hIAPP redox state. Fibrils 
were prepared under the three redox conditions described in (A–C). Before the NMR experiment, fibrils were 
dissolved in organic solvent. (F) Model of the hIAPP aggregation mechanism. ER stress results in production 
of a small amount of hIAPPred in the cell. hIAPPred aggregates preferentially and is depleted from the pool of 
soluble molecules in the cell. Redox buffering continuously converts hIAPPox into hIAPPred. This way, hIAPP 
might assist in regenerating redox equivalents under ER stress conditions.
www.nature.com/scientificreports/
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Figure 3. (A) Circular dichroism (CD) spectra of reduced (red) and oxidized hIAPP (black). hIAPPox yields a 
negative band at 222 nm and 208 nm which is characteristic for an α -helical conformation. The reduced form 
shows a considerably smaller band at 222 nm indicating a larger degree of random coil conformation.  
(B) NMR structural ensemble of hIAPPox(1-37). The structure was determined at pH 5.3 and at a temperature 
of 4 °C, using the software package CYANA21. (C) Structure of one conformer of the hIAPP ensemble. hIAPPox 
adopts an α -helix structure involving residues 8–17, and is disordered in its C-terminal part. The disulfide 
bridge is indicated in yellow. The hIAPP structural ensemble was deposited in the PDB (PDB ID: 5MGQ). 
RDC experiments confirm that the N-terminal part of hIAPP adopts a compact structure (Fig. S4). (D) 
Representative strips from 3D NOESY experiments. The NOE pattern of the respective residues demarcates 
the boundaries of the α -helical structure of hIAPP. E) 13Cα/β secondary chemical shift analysis. Differences 
of deviations from random coil chemical shifts for Cα and Cβ (δ Δ , ppm) are represented as a function of the 
primary sequence. hIAPPred is shown in red. Reduction was induced by adding 10 mM TCEP. The oxidized 
peptide was obtained by addition of 2 mM H2O2 (black). Secondary Structure Propensity (SSP) of hIAPPox 
in aqueous buffer, pH 5.3, is shown in Fig. S3. (F) Heteronuclear NOEs of hIAPP. The hetNOE data confirms 
that the N-terminus of hIAPP has a high propensity to form a compact structure. (G) Experimental short and 
medium range NOE connectivities in hIAPP. (H) Number of NOE restraints per residue employed for hIAPP 
structure calculation. The inset displays the number of NOE restraints observed between residue i and j. Only 
four long range connectivities (residues i and j, with |i − j| > 5) are observed for the residues around the disulfide 
bridge (denoted with an asterisk in the inset).
www.nature.com/scientificreports/
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Discussion
Stabilization of the monomeric state of a protein can prevent its conversion into an aggregated state22. This par-
adigm is generally accepted for folded proteins, but has so far not been recognized for disordered peptides and 
proteins. We show here that the oxidized form of the islet hormone hIAPP is more structured in comparison to 
the reduced form of the peptide, and at the same time has a smaller propensity to aggregate. We find furthermore 
that the pancreatic islets of a T2D mouse model contain primarily aggregated hIAPP in its reduced state. We sug-
gest that differential aggregation unleashes redox equivalents that potentially counteract oxidative stress.
Initially, it was suggested that hIAPP adopts a random coil structure23. However, more recently reports indicate 
that the N-terminal part of hIAPP involving residues 5–19 and to a somewhat smaller degree residues 20–22 tran-
siently samples an α -helical structure in solution8,24. The same residues adopt a fully helical structure when bound 
to membranes or micelles19,24,25. In agreement with previous studies, we found that reduction of the N-terminal 
disulfide bond (Cys2–Cys7) in solution decreases the extent of helix formation in this region26. Miranker and 
coworkers observed that formation of helical structure is directly correlated with enhanced amyloid formation on 
a membrane surface. It was suggested that a parallel association of helices results in locally increased peptide con-
centration that could nucleate β -strand structure. By contrast, we find that the reduced form of hIAPP aggregates 
significantly faster than the oxidized peptide. Our data can be reconciled with the observation made by Miranker 
and coworkers by assuming that membranes can favor an α -helical structure e.g. by formation of an amphipatic 
helix. At the same time, an increase of the local protein density can be a very strong driving force for aggregation. 
In aqueous buffer, the situation is fundamentally different. The α -helical propensity at the N-terminus of hIAPP 
impedes conversion into β -sheet structure. Solid-state NMR studies showed that hIAPP adopts a strand–turn–
strand structure in amyloid fibrils, with the N-terminal and C-terminal strands involving residues 8–17 and res-
idues 28–37, respectively27,28. The residues in-between the disulfide bridge do not contribute to the amyloid fiber 
core structure. At the same time, the disulfide bridge plays a central role in the fibril assembly mechanism29: Loss 
of the disulfide bond substantially reduces fiber formation by secondary nucleation, and eliminates the activation 
step in seeded fiber growth30.
Obviously, the expression level of hIAPP has a strong impact on solubility and aggregation propensity of the 
peptide. Insulin and hIAPP tend to be regulated in parallel. Hyperglycemia, however, has been shown to result in 
disproportionate upregulation of hIAPP versus insulin, thus altering the ratio of hIAPP to insulin secreted by the 
β -cells31. Increased secretion of hIAPP in severe hyperglycemia has been suggested to facilitate the formation of 
NMR distance and dihedral constraints
Distance constraints
 Total NOE 542
 Intra-residue 136
 Inter-residue 406
  Sequential (|i − j| = 1) 218
  Medium-range (|i − j| < 4) 184
  Long-range (|i − j| > 5) 4
Total dihedral angle restraints 20
 φ 10
 ψ 10
Structure statistics
Violations (mean ± s.d.)
 Distance constraints (Å) 0.019 ± 0.002
 Dihedral angle constraints (°) 0.767 ± 0.133
 Max. dihedral angle violation (°) 3.02
 Max. distance constraint violation (Å) 0.25
Deviations from idealized geometry
 Bond lengths (Å) 0.014 ± 0.001
 Bond angles (°) 1.636 ± 0.043
 Impropers (°) 1.789 ± 0.155
Average pairwise r.m.s. deviation* (Å)
 Heavy 0.78 ± 0.31
 Backbone 0.27 ± 0.09
Ramachandran plot statistics (%)
 Residues in most favoured regions 68.0
 Residues in additionally allowed regions 30.6
 Residues in generously allowed regions 0.9
 Residues in disallowed regions 0.5
Table 1. Structural statistics of hIAPP (residues 1-37). *Pairwise r.m.s. deviation was calculated among 20 
refined structures for residues 2–17.
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hIAPP-derived islet amyloid deposits31. At the same time, disturbances in redox regulation, calcium homeostasis, 
glucose deprivation, and viral infection can lead to ER stress32. Under these conditions, the folding of proteins 
is slowed down, leading to an increase of unfolded proteins. Unfolded proteins cause a stress response in the ER 
which is known as unfolded protein response (UPR)33. ER stress is emerging as a potential cause of damage in 
hypoxia/ischemia, insulin resistance, and other disorders34. In T2D, pancreatic β -cells undergo cell death as a 
consequence of sustained ER stress35,36. We find that reduced hIAPP aggregates 3-times faster in comparison to 
the oxidized form of the peptide. This differential aggregation results in a continuous conversion of hIAPPox into 
hIAPPred in the ER. Thus, oxidation equivalents are continuously restored in the ER, a mechanism that might 
aid to counteract ER stress. Given the fact that hIAPP occurs at concentrations up to 4 mM in the cell37,38, hIAPP 
might act as a buffering system. This process works as long as the resulting aggregates are efficiently removed. 
Clearance can be achieved via autophagy and degradation in the lysosome. It has been shown that β -cell apoptosis 
is in fact correlated with autophagy and lysosomal degradation39–41. Inhibition of autophagy induces apoptosis, 
whereas stimulation of autophagy protects β -cells from hIAPP-induced toxicity. Alternatively, the endoplasmic 
reticulum–associated degradation (ERAD) assists to protect cells from ER stress42. It has been reported that accu-
mulation of polyubiquitinated proteins occurs in pancreatic islets of hIAPP transgenic mice but not in mice 
with comparable transgenic expression of rodent-IAPP (r-IAPP). Proteasome dysfunction can mediate obesity 
induced ER stress and insulin resistance43. In fact, it has been found that the β -cell ERAD/ubiquitin/proteasome 
system of obese individuals with high BMI, that are otherwise healthy and not suffering from T2D, adapts to the 
increased synthetic burden of insulin and IAPP44. p62, an important factor in the autophagy/lysosomal pathway, 
is downregulated by overproduction of hIAPP in diabetic β -cells, resulting in induction of apoptosis39,45.
By contrast, the percentage of β -cells with ubiquitin-positive immunostaining was significantly increased in 
obese individuals with T2D. This may suggest that misregulation of proteasomal degradation yields an accumula-
tion of aggregates which may eventually lead to perturbations in redox balance. In vivo, expression of other factors 
such as BiP, HSP70 and DnaJ which are known to interact with hIAPP can modulate the aggregation behav-
iour46. Similar to the small heat shock proteins such as α B-crystallin that interacts sub-stoichiometrically with 
Alzheimer’s disease Aβ 47, HSP70 and GRP78/BiP can detect and bind misfolded hIAPP oligomers. Chaperones 
thus would have an influence ensuring proper redox balance.
Recently, it has been shown that the redox status of the microsomal protein folding machinery is affected 
in diabetes48. Streptozotocin-induced diabetes in rats results in a significant increase in the content of free pro-
tein sulfhydryl groups, as well as in the amount of free sulfhydryl groups of the major protein disulfide isomer-
ases (PDIs), in particular the 58 kDa PDI and the 57 kDa ERp57. In this chemically induced diabetes model, 
hIAPP is overexpressed relative to insulin49. Our data revealed the redox potential of hIAPP to be on the order of 
(− 129 ± 4) mV suggesting that a significant amount of hIAPP in the ER actually exists in the reduced state. A 
shift of the redox conditions under ER stress to a more reducing state, and an increase in the amount of produced 
hIAPP in T2D would immediately result in enhanced hIAPP aggregation. As a consequence of aggregation, even 
more redox equivalents would become available to restore the oxidizing redox environment of the ER.
Taken together, we have shows that aggregation of hIAPP can have beneficial effects on the well-being of the 
cell by restoring redox equivalents in the due course of aggregation. Only failure of the preoteasome degradation 
machinery results in β -cell disruption. It remains to be seen which molecular mechanisms in more detail induce 
a misfunction of proteasomal degradation in T2D.
Materials and Methods
Recombinant protein expression and purification.  Human IAPP was expressed in E. coli and purified 
using the protocol described previously17. This protocol allows the production of an isotopically enriched pep-
tide, which is amidated at the C-terminus and is disulfide bridged involving residues Cys-2 and Cys-7. Molecular 
biology reagents were obtained from Roche, New England Biolabs and from Sigma-Aldrich St. Louis, MO, USA. 
Isotopically labeled minimal media components were purchased from Cambridge Isotope Laboratories (CIL).
Isolation of mouse islets. hIAPP transgenic mice were purchased from Jackson Laboratory (Bar Harbor, 
USA) and studied between 13–18 weeks of age. Animals were killed by isoflurane overdose and islets were iso-
lated immediately. To perfuse the pancreas, the common bile duct was clamped at the papilla of Vater and 1 mg/ml 
cold collagenase P solution in HBSS solution supplemented with 1% BSA was injected into the common bile duct. 
The pancreas was removed and incubated for 15 min at 37 °C. Digestion was stopped by addition of a cold HBSS 
solution supplemented with 1% BSA and centrifuged at 290 g for 2 min at 4 °C. The pellet was resuspended in the 
HBSS solution supplemented with 1% BSA, filtered through a metal mesh and centrifuged at 290 g for 2 min at 
4 °C. The pellet was resuspended in 15% Optiprep supplemented with 3.75 mM HEPES, 12% PBS, 6.2% RPMI and 
layered onto 15% Optiprep supplemented with 3.75 mM HEPES, 12% PBS, 6.2% RPMI solution. The pancreatic 
lysate was overlaid with the HBSS solution supplemented with 1% BSA, incubated for 10 min and centrifuged at 
360 g for 18 min at 4 °C. After centrifugation, islets were observed in the interface between the first and second 
layers and after collecting islet fraction, cell debris were filtered through a 70 μ m cell strainer and islets were 
washed from the filter with RPMI supplemented with 11 mM glucose, 10% FBS, antibiotic-antimycotic solution. 
To eliminate remaining exocrine tissue, the islets were handpicked and transferred into a new culture dish.
Animals were declared to the responsible local authority (Regierung von Oberbayern). The Institutional 
Animal Welfare Officer (Helmholtz-Zentrum München) was consulted about the work and approved the study. 
All experiments were performed in accordance with relevant guidelines and regulations.
Western Blot Analysis. Extracted islets were solubilized with 30 μ L PBS buffer supplemented with NEM 
and vortexed. Subsequently, 10 μ L of SDS sample buffer without reducing agent was added. Samples were boiled 
for 5 min at 90 °C and separated by 12% Mini-PROTEAN-TGX stain-FreeTM protein gels, and then transferred 
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onto a Tnas-Blot-TurboTM Mini PVDF membrane with a Bio-Rad Trans-Blot TurboTM transfer system. Membrane 
was blocked in Tween-Tris-buffered saline with 5% (w/v) nonfat dry milk (Roth) for 1 hour and then incubated 
with the primary antibody A133 in Tween-Tris-buffered saline with a ratio 1:1000 overnight at 4 °C. Reactivity 
was analyzed with antirabbit peroxidase-conjugated secondary antibody (Serva) and chemiluminescence detec-
tion (Bio-Rad).
hIAPP fibril antibody production.  To generate a monoclonal antibody against hIAPP amyloid fibrils, syn-
thetic human lyophilized HFIP-treated hIAPP was dissolved in 20 mM Tris buffer (pH 7.4) to a concentration of 
30 μ M. The solution was sonicated for 1 min and incubated for 2 d at 37 °C with shaking at 300 rpm. The resulting 
fibrils were used for antibody generation according to a proprietary immunization protocol of Synaptic Systems 
Göttingen (see also http://www.sysy.com/mabservice.html): Three 8–10-week-old BALB/c female mice were 
subcutaneously immunized with IAPP fibrils over a period of 17 days. Cells from the knee lymph nodes were 
fused with the mouse myeloma cell line P3 × 63Ag8.653 (ATCC CRL-1580). The clones used in this study were 
re-cloned two times by limiting dilution and the immunoglobulin subclass was determined. Antibodies secreted 
by the hybridomas were screened for their reactivity against the immunogen using ELISA. Positive antibodies 
were retested by ELISA against hIAPP fibrils and monomer. Hybridomas producing antibodies with preference 
for IAPP fibrils were subcloned to monoclonality and further analyzed for histology and western blot applica-
tions. One of the antibodies showing high specificty for hIAPP fibrils was the antibody 91D7E8.
Immunofluorescence staining of pancreatic β-cells. Pancreata were fixed in 4% paraformalde-
hyde and processed as published previously50. Briefly, cryo-sections were stained with anti-insulin (Invitrogen, 
Life Technologies, Germany), or with anti-amyloid fibril antibody 91D7E8 employing corresponding 
fluorescent-labeled secondary antibodies (Invitrogen, Life Technologies, Germany). DAPI was used to visualize 
cell nuclei. Slides were scanned using a NanoZoomer 2.0 HT (Hamamatsu, Japan) fluorescence scanner.
NMR sample preparation. Lyophilized hIAPP(1-37) was dissolved into NMR buffer (30 mM deuterated 
acetic acid, pH 5.3) containing 10% D2O for locking. The samples were measured and stored at 4 °C. The forma-
tion of the intramolecular disulfide bond was confirmed by NMR. To prepare hIAPP in the oxidized state, a hIAPP 
solution was supplemented with 0.2 mM GSSG. To generate the reduced form of the peptide, the GSH powder was 
directly added to the hIAPP solution to yield a final concentration of 35 mM of reduced glutathione. To produce 
the hIAPPred:hIAPPox = 50:50 mixed sample, the hIAPP stock solution was added to a glutathione solution with 
final concentrations of 0.2 mM GSSG and 4.98 mM GSH. The final hIAPP concentration amounted to 100 μ M 
in all cases. Afterwards, the samples were incubated at 4 °C to allow for complete oxidation or reduction.
For analysis of the oxidation state of the aggregated hIAPP samples at varying redox conditions, peptides were 
incubated first for two weeks at 37 °C to allow for fibril formation. After this period, samples were centrifuged 
for 30 min to harvest the fibrils. Pellets were dissolved in 250 μ L of d6-DMSO, and subsequently sonicated for 
1 hour. In order to prevent degradation of hIAPP, ice was added into the sonication bath to avoid sample heating. 
Afterwards, samples were directly transferred into Shigemi NMR tubes (Shigemi Inc., Allison Park, USA) for 
solution-state NMR measurements.
NMR Experiments. All NMR experiments were performed at 4 °C, employing Bruker Avance 500, 600, 
750 MHz spectrometers, equipped with cryo-probes. The proton chemical shifts were referenced to the water 
resonance frequency, the 15N and 13C shifts were referenced indirectly. Backbone and side chain assignments were 
obtained using triple resonance experiments51. Side chain assignments were obtained from 3D-HCCH TOCSY 
experiments. Overall, an assignment completeness of 97% was obtained. NMR spectra were processed using the 
software TopSpin (Bruker) and NMRPIPE52. Spectra were analyzed using SPARKY53 and ccpNMR analysis54.
Structure Calculation. Sequential and inter-residual NOE cross-peaks that could be resolved in the 
15N-edited spectrum were assigned manually for the N-terminal half and were kept fixed during structure 
calculations with CYANA21. Peak intensities for all cross-peaks were converted to distances using the internal 
function of CYANA. Dihedral angle restraints were derived from chemical shifts using the program TALOS55,56. 
Distance and angle restraints were used as input for the calculation of the structure on a linux-based cluster. All 
non-violated structures were recalculated using a water-refinement protocol.
Transmission electron microscopy (TEM).  Samples were stained with 1% uranyl acetate solution on 
Formvar/Carbon 300 mesh copper coated grids from Electron Microscopy Sciences (Hatfield, PA 19440, USA). 
10 μ L of the sample were placed on the grid for 1 min. The excess of the sample was dried using filter paper. After 
this process, the grid was washed by placing it three times on a drop of water for 3 s. For staining, the grid was 
placed on a drop of a uranyl acetate solution for 30 s. The excess of the solution was again dried using filter paper. 
Samples were measured immediately employing an EM 10 CR (Zeiss, Germany).
Determination of the hIAPP redox potential. 100 μ M hIAPPox was initially dissolved in 500 μ L NMR 
buffer, containing 0.2 mM oxidized glutathione (GSSG). The GSH concentration was then increased stepwise to 
yield a final GSH concentration of 0.2, 1.0, 3.0, 5.0, 7.0, 10.0, 12.0, 15.0 and 18.0 mM, using a 100 mM GSH stock 
solution. 1H,15N-HSQC spectra were recorded after each addition of GSH. To determine the redox potential, the 
intensity of Cys-7 was determined in each spectrum. The intensities of the Cys-7 cross peak were plotted as a 
function of [GSH]2/[GSSG] on a logarithmic scale, and fit assuming a sigmoidal behavior. The [GSH]2/[GSSG] 
titration half-point was determined as 0.24 M. The redox potential for the GSH/GSSG redox pair was assumed to 
be − 151 mV13. The Nernst equation yields then a redox potential for hIAPP of − 129+ /− 4 mV.
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Circular Dichroism Spectroscopy (CD).  CD experiments were carried out at room temperature employing 
a JASCO spectropolarimeter. Quartz cells with a path length of 0.1 cm were used. Spectra were recorded between 
260 nm and 190 nm at 0.1 nm intervals, with a response time of 1 s. For the analysis of the data the background 
buffer was subtracted and the data were expressed as mean residue ellipticity θMRW = (deg cm2 dmol−1) × 10−6.
Thioflavin-T assay.  Fluorescence experiments were performed using a Beckman fluorometer, using Quartz 
cells with a path length of 1 cm. The samples were freshly prepared with the dye ThT, and incubated in the cell 
while stirring at 37 °C. The solutions were prepared by adding NMR buffer (30 mM d-acetic acid, pH 5.3) to 
the dried peptide immediately prior to the measurements, holding the solution on ice all the time. A ThT stock 
solution was prepared in NMR buffer at a concentration of 25 mM. Final concentrations for the ThT experiment 
were 30 μ M hIAPP and 10 μ M ThT. The data were analyzed using the software Origin (OriginLab Corporation, 
Northampton, MA 01060, USA), and were fit assuming a sigmoidal behavior.
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